EFTA02435791.pdf
PDF Source (No Download)
Extracted Text (OCR)
To:
Jeffrey Epstein[jeevacation©gmail.com]
From:
Sarah
Sent:
Tue 11/10/2009 5:01:13 PM
Subject: Fw: GO3 next step partnership
FYI
This email and any files transmitted with it are confidential and intended solely for the use of the
individual or entity to whom they arc addressed. If you have received this email in error please
notify the sender
immediately.
From: "Samson, Imelda"
Date: Mon, 9 Nov 2009 14:24:38 -0500
To: Tovc Skarshcim
Cc: Geir Fra
Sarah<
Tsai, Jennife
Subject: RE: GO3 next step partnership
I had forwarded everything to Dr. Fuster and according to his academic administrative assistant Jennifer
Tsai, it is all being taken cared of.
If you need anything else — let me know.
Imelda
From: Tove Skarsheim [mailto
Sent: Friday, November 06, 2009 6:48 AM
To: Samson, Imelda
Cc: Geir Frantzen; Sarah
Subject: G03 next step partnership
Dear Imelda,
Thank you so much for sending over the study yesterday. Very interesting work.
We are very pleased that Dr. Fuster is interested in working with the Duchess of York and the rest of the
GO3 team on this project. I had the pleasure of meeting Dr. Fuster a while back, and I know that he has
had some good meetings and dialogue around the project with the Duchess since then. We are looking
very much forward to taking this to the next level. Please find some thoughts around the partnership
EFTA_R1_01508006
EFTA02435791
below as promised to Dr.Fuster in the last meeting.
We have been told by Geir Frantzen that Dr.Fuster and the team would be interested in doing a piece of
research on the GO3 products showing the benefits of Omega-3. We are very interested in conducting
such a project with a professional team, as this could be a fantastic opportunity to get this important
message out to as many people as possible through our excellent spokes people and to build a strong
brand for Omega-3.
I am not sure about how much detail that has been communicated around the actual research project so
far in the meetings with Dr. Fuster, the Duchess and Geir Frantzen. From our point of view, the next step
of this should be a discussion with the team to understand what kind of research Dr. Fuster had in mind
when suggesting this. We would also like to present the new product formulation to Dr. Fuster, as the
testing should be done on this specific product. The product will be a highly concentrated Omega-3 oil
with added D-vitamins. More detail on product specification will come later as this is still in the
development phase. We would see it as an advantage for the project going forward that Dr. Fuster and
his team can see the product in the development phase as they might have feedback on the formulation.
GO3 is delighted about the opportunity to work with the very best within this field. We believe that this
project will bring a lot of benefits to the partners involved and will work on finding a partnership model
that will benefit all parties.
It is our understanding that Dr. Fuster wants to create funds for the important work and research that is
done through his organization. There are different ways of setting this up, but we would like to discuss a
model first where every purchase gives a contribution to building these funds. This could be combined
with a first time contribution that will work as a start up fee for the research and to get the partnership
going. The actual numbers on these elements and payment terms will be discussed between Keith
Frankel, Geir Frantzen and Dr. Fuster.
Furthermore, when the brand is profitable and running we can create special campaigns for the fund to
create attention around special projects. Having a percentage of every purchase being donated to the
fund will secure a income stream to the project over time and will also give the opportunity for
American consumers to feel involved in supporting an important cause.
To build the credibility of the brand we would in return like Dr. Fuster to be involved in the GO3 brand
out to the consumers. We need to discuss how this can be done in a manner that will suit all involved ,
but the elements we would like to discuss are:
Use of quotes from Dr. Fuster about the benefits of Omega-3 on the GO3 website
Use of references to the research on the web site
Use of quotes or interview with Dr. Fuster in the infomercial
Usc of research reference on pack after research has been conducted.
Usc of reference to Dr. Fuster in PR initiatives
EFTA_R1_01508007
EFTA02435792
I hope that this can create a platform for further discussions. Please don't hesitate to contact me if you
have any immediate questions.
Best regards,
Tove Skarsheim
Marketing Director GO3
This email is for the intended recipient only and is confidential. If this email has been
misdirected, please let the sender know and delete it. Any disclosure, copying,
distribution is prohibited.
Although we take great care to protect our network from computer viruses, we accept
no responsibility for mail-borne viruses and recommend that you scan the email and its
attachments. If you do find any virus please let us know so that we may take
appropriate action.
For the legal protection of our business any email sent or received by us may be
monitored or intercepted.
EFTA_R1_01508008
EFTA02435793
Document Preview
PDF source document
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
Extracted Information
Document Details
| Filename | EFTA02435791.pdf |
| File Size | 270.0 KB |
| OCR Confidence | 85.0% |
| Has Readable Text | Yes |
| Text Length | 5,322 characters |
| Indexed | 2026-02-12T16:58:17.996911 |